Sep 28, 2026
Neola Medical’s CEO Hanna Sjöström presented at BioStock Life Science Summit 2026, highlighting the progress made during the year and the company’s path toward the next phase of U.S. developmentIn the presentation, Hanna Sjöström...
Sep 21, 2026
Neola Medical AB will participate in BioStock’s investor event “Investing in Life Science – From Seed to Success” in Stockholm on September 22, 2026.CEO Hanna Sjöström will present Neola Medical’s latest progress and strategic...Sep 7, 2026
Neola Medical’s CEO Hanna Sjöström has been interviewed by Redeye Equity Research Analyst Oscar Bergman following the FDA’s decision to grant Neola® Breakthrough Device Designation.In the interview, Hanna Sjöström discusses the...Sep 4, 2026
Neola Medical AB (publ) today announces that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for Neola®, the Company’s medical device for non-invasive, continuous lung monitoring in preterm born babies, with the...Aug 31, 2026
Neola Medical AB (publ) today announces that the United States Patent and Trademark Office (USPTO) has granted the company a design patent covering the graphical user interface of Neola®. The patent further strengthens Neola Medical’s intellectual property...This website uses cookies to enhance your experience. Some are essential for site functionality, while others help us analyze and improve your usage experience. Please review your options and make your choice.
If you are under 16 years old, please ensure that you have received consent from your parent or guardian for any non-essential cookies.
Your privacy is important to us. You can adjust your cookie settings at any time. For more information about how we use data, please read our privacy policy. You may change your preferences at any time by clicking on the settings button below.
Note that if you choose to disable some types of cookies, it may impact your experience of the site and the services we are able to offer.
Some required resources have been blocked, which can affect third-party services and may cause the site to not function properly.
